“Be Clinical, an Indian skincare brand, has raised Rs 6 crore in seed funding led by V3 Ventures, with Titan Capital also participating. Founded by Hemangi Dhir, Be Clinical focuses on evidence-led skincare tailored for Indian skin. The funds will boost R&D, clinical testing, and in-house formulation to address ageing concerns. Be Clinical emphasizes transparency, education, and measurable results, differentiating itself through clinically validated formulations and in-house research. Having served 25,000 customers, they plan to expand their manufacturing and upgrade packaging. Key competitors include Olay, Neutrogena, Clinique, and Dr. Sheth. #IndianSkincare
Trending
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset
- IIT Madras Director Unfazed by India’s AI Sovereignty Concerns
- Flipkart Bolsters Leadership with Key VP Appointments
- IEA Warns Current Oil Crisis Exceeds Past Shocks
- HomeEssentials Secures $7.7M to Fuel Retail Expansion


